SciCann Therapeutics is a pharmaceutical company dedicated to the development and commercialization of therapeutic products that target and modulate the endocannabinoid system. It specializes in the fields of oncology, pain management, neurodegenerative diseases, and inflammatory disorders. The company discovers and develops technologies and products in the cannabinoid space, including new therapeutic agents, drug candidates, cannabis genetics, personalized treatment tools, etc.